T. Clausen et al., Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia, BR J OBST G, 108(10), 2001, pp. 1081-1087
Objective To investigate whether hypertriglyceridemic dyslipidemia is a ris
k factor for either early or late onset pre-eclampsia.
Design Prospective cohort study and nested case-control study.
Setting Aker Hospital: a university hospital with all levels of obstetric c
are.
Participants 2157 Caucasian pregnant women.
Methods Blood samples were obtained from non-fasting subjects at 18 weeks o
f gestation. All samples were analysed for triglycerides, total-cholesterol
, high density lipoproteins cholesterol and non-high density lipoproteins c
holesterol. ApoB-100 were analysed in pre-eclamptic women and in 3:1 matche
d controls. The cohort data were analysed by multiple logistic regression a
nd the case-control data by conditional logistic regression.
Main outcome measures Adjusted odds ratios of early and late onset pre-ecla
mpsia according to early second trimester serum concentration levels of lip
ids and ApoB-100.
Results Eighteen women developed early onset pre-eclampsia and 53 women dev
eloped late onset pre-eclampsia. In the cohort model, women with triglyceri
des above 2.4 mmol/L had increased risk (OR 5. 1; 95% Cl 1.1-23.1) of early
onset pre-eclampsia compared with those with triglycerides levels less tha
n or equal to 1.5mmol/L. For women with high triglycerides: non-high densit
y lipoproteins cholesterol ratios (> 90 centile) the OR (95% CI) for early
onset pre-eclampsia was 7.1 (2.3-22.0) compared with those with low ratios
(less than or equal to 50 centile). Similar associations were found in the
case control model. We found no associations between plasma lipids and risk
of late onset pre-eclampsia.
Conclusions Hypertriglyceridemic dyslipidemia before 20 weeks of gestation
is associated with the risk of developing early but not late onset pre-ecla
mpsia, giving support to the contention that these two variants of the dise
ase are at least partly pathogenically different.